Dr. Monzr M. Al Malki
Claim this profileCity of Hope Medical Center
Area of expertise
Acute Myelogenous Leukemia
Monzr M. Al Malki has run 13 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Myelodysplastic Syndrome
Monzr M. Al Malki has run 11 trials for Myelodysplastic Syndrome. Some of their research focus areas include:
Affiliated Hospitals
City Of Hope Medical Center
City Of Hope
Clinical Trials Monzr M. Al Malki is currently running
Music Therapy
for Anxiety in Blood Cancer Procedures
This phase III trial compares the effect of adding passive music when undergoing bone marrow biopsy/aspirate versus bone marrow biopsy/aspirate alone in reducing anxiety. Music therapy helps relieve pain or stress and promote well-being. Listening to music during a bone marrow biopsy/aspirate procedure may reduce anxiety during the procedure.
Recruiting
2 awards
Phase 3
5 criteria
Vedolizumab + Cyclophosphamide + Tacrolimus
for Graft-versus-Host Disease
This phase II trial studies how well vedolizumab plus post-transplant cyclophosphamide (PTCy) and short course tacrolimus work for the prevention of graft versus host disease (GVHD) in patients undergoing allogeneic hematopoietic cell transplantation (HCT) after reduced intensity conditioning. Allogeneic HCT is a procedure in which a person receives blood-forming stem cells (cells from which all blood cells develop) from a donor. Giving reduced conditioning chemotherapy before an allogeneic HCT helps kill cancer cells in the body and helps make room in the patient's bone marrow for new stem cells to grow using less than standard doses of chemotherapy. Sometimes, the transplanted cells from a donor can attack the body's normal cells (called graft-versus-host disease). Vedolizumab is a monoclonal antibody, which is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). It may reduce inflammation. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid and may kill cancer cells. It may also lower the body's immune response. Tacrolimus suppresses the immune system by preventing the activation of certain types of immune cells. Giving vedolizumab plus PTCy and short course tacrolimus may be effective at preventing GVHD after allogeneic HCT.
Recruiting
1 award
Phase 2
10 criteria
More about Monzr M. Al Malki
Clinical Trial Related
3 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Monzr M. Al Malki has experience with
- Cyclophosphamide
- Tacrolimus
- Fludarabine
- Melphalan
- Allogeneic Hematopoietic Stem Cell Transplantation
- Mycophenolate Mofetil
Breakdown of trials Monzr M. Al Malki has run
Acute Myelogenous Leukemia
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Monzr M. Al Malki specialize in?
Monzr M. Al Malki focuses on Acute Myelogenous Leukemia and Myelodysplastic Syndrome. In particular, much of their work with Acute Myelogenous Leukemia has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Monzr M. Al Malki currently recruiting for clinical trials?
Yes, Monzr M. Al Malki is currently recruiting for 8 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Monzr M. Al Malki has studied deeply?
Yes, Monzr M. Al Malki has studied treatments such as Cyclophosphamide, Tacrolimus, Fludarabine.
What is the best way to schedule an appointment with Monzr M. Al Malki?
Apply for one of the trials that Monzr M. Al Malki is conducting.
What is the office address of Monzr M. Al Malki?
The office of Monzr M. Al Malki is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.